Clinical Trial Update: PSD502 in Subjects With Premature Ejaculation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for PSD502 in Premature Ejaculation is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• PSD502

Snippet

Sponsor: Plethora Solutions Ltd | Conditions: Premature Ejaculation | Phase 2 | Status: COMPLETED